In contrast, a pan-cancer study examining the effect of ATM variants on radiation therapy response observed a trend toward improved progression-free survival among patients with lung cancer who had loss-of-function ATM mutations (hazard ratio 0.49, [95% CI, 0.23-1.04]).13 This evidence concerns the gene ATM and cancer.